Unusual Right‐Sided Cardiac Masses

M. Leitman,Ehud Rahanani,I. Wassermann,S. Rosenblatt,E. Peleg,R. Krakover,B. Zuckermann,T. Fuchs,Nick Theodorovich,Z. Vered

DOI: https://doi.org/10.1111/j.1540-8175.2010.01264.x

2010-10-01

Echocardiography

Abstract:(Echocardiography 2010;27:1151‐1155)

What problem does this paper attempt to address?

Association Between Bone Mineral Density and Type 2 Diabetes Mellitus: a Meta-Analysis of Observational Studies

Lili Ma,Ling Oei,Lindi Jiang,Karol Estrada,Huiyong Chen,Zhen Wang,Qiang Yu,Maria Carola Zillikens,Xin Gao,Fernando Rivadeneira

DOI: https://doi.org/10.1007/s10654-012-9674-x

2012-01-01

European Journal of Epidemiology

Abstract:Type 2 diabetes mellitus (T2DM) influences bone metabolism, but the relation of T2DM with bone mineral density (BMD) remains inconsistent across studies. The objective of this study was to perform a meta-analysis and meta-regression of the literature to estimate the difference in BMD (g/cm(2)) between diabetic and non-diabetic populations, and to investigate potential underlying mechanisms. A literature search was performed in PubMed and Ovid extracting data from articles prior to May 2010. Eligible studies were those where the association between T2DM and BMD measured by dual energy X-ray absorptiometry was evaluated using a cross-sectional, cohort or case-control design, including both healthy controls and subjects with T2DM. The analysis was done on 15 observational studies (3,437 diabetics and 19,139 controls). Meta-analysis showed that BMD in diabetics was significantly higher, with pooled mean differences of 0.04 (95% CI: 0.02, 0.05) at the femoral neck, 0.06 (95% CI: 0.04, 0.08) at the hip and 0.06 (95% CI: 0.04, 0.07) at the spine. The differences for forearm BMD were not significantly different between diabetics and non-diabetics. Sex-stratified analyses showed similar results in both genders. Substantial heterogeneity was found to originate from differences in study design and possibly diabetes definition. Also, by applying meta-regression we could establish that younger age, male gender, higher body mass index and higher HbA(1C) were positively associated with higher BMD levels in diabetic individuals. We conclude that individuals with T2DM from both genders have higher BMD levels, but that multiple factors influence BMD in individuals with T2DM.
Bone mineral density and factors influencing it in Asian Indian population with type 2 diabetes mellitus

Sadishkumar Kamalanathan,Vimal Nambiar,Vyankatesh Shivane,Tushar Bandgar,Padmavathy Menon,Nalini Shah

DOI: https://doi.org/10.4103/2230-8210.140268

2014-01-01

Indian Journal of Endocrinology and Metabolism

Abstract:OBJECTIVE: To assess bone mineral density (BMD) in type 2 diabetes mellitus (T2DM) patients and its relation, if any, to clinical, hormonal and metabolic factors.MATERIALS AND METHODS: A prospective evaluation of 194 T2DM patients (97 men and 97 women) was carried out. BMD was done with dual energy X-ray absorptiometry (DXA) at the lumbar spine and total hip. Physical activity, nutritional intake and sunlight exposure were calculated. Biochemical and hormonal tests included serum 25 hydroxy vitamin D [25(OH) D], parathyroid hormone, estrogen, testosterone and urinary calcium-creatinine ratio. Glycosylated hemoglobin and complete lipid profiles were done in patients with diabetes. Five hundred and seventy one non-diabetic controls (262 males and 309 females) were evaluated for BMD alone.RESULTS: BMD was normal (Z score > -2) in 156 (80.5%) and low (Z score ≤ -2) in 38 (19.5%) patients in the diabetes study group. BMD in the diabetes group was significantly higher than the control group in both sexes at the hip and spine. The difference was no longer significant on analysis of a BMI matched control subgroup. Weight and BMI showed significant correlation to BMD. Duration of T2DM, degree of glycemic control, use of drugs like statins and thiazolidinediones, 25(OH) D levels, calcium intake, sunlight exposure and physical activity did not significantly affect BMD in this cohort of individuals with diabetes.CONCLUSIONS: Bone mineral density of Asian Indian T2DM subjects was similar to that of healthy volunteers in this study.
The effects of anesthesia on middle‐eae effusions

M. Fried,D. Vernick,J. Kelly,Victoria Silberstein,M. Strome

DOI: https://doi.org/10.1288/00005537-198801000-00006

IF: 2.97

1988-01-01

The Laryngoscope

Abstract:Surgeons occasionally note a discrepancy between preoperative assessment of middle‐ear effusion and operative observation during the placement of ventilating tubes in children's ears. This study was designed to determine whether this variance is secondary to the effects of inhalation anesthesia or misinterpretation of the preoperative exam. Observations were recorded by three distinctly different methods of measurement: the surgeon, the MD‐2 Impedance Analyzer, and the Acoustic Otoscope® immediately before and after induction of anesthesia. These results were then analyzed and compared with the operative findings. Anesthetic induction was shown to cause alteration in the presence of middle‐ear fluid in less than 10% of cases.
Bone Mineral Density and Its Relationship with Body Mass Index in Postmenopausal Women with Type 2 Diabetes Mellitus in Mainland China

Peng-Fei Shan,Xian-Ping Wu,Hong Zhang,Xing-Zhi Cao,Wei Gu,Xiao-Ge Deng,Chi Gu,Er-Yuan Liao

DOI: https://doi.org/10.1007/s00774-008-0023-9

2009-01-01

Journal of Bone and Mineral Metabolism

Abstract:Bone mineral density (BMD) and its association with body mass index (BMI) are uncertain in postmenopausal women with type 2 diabetes mellitus (T2DM) in mainland China. This study was performed to assess this association including 1,042 postmenopausal women with T2DM and 919 non-diabetic control subjects. Bone mineral density of the posteroanterior spine and of the left hip was measured by use of dual-energy X-ray absorptiometry. Diabetic participants were divided into three groups according to BMI, i.e. low BMI (DML < 18.5 kg/m2), intermediate BMI (DMM 18.5–24.9 kg/m2), and high BMI (DMH ≥ 25 kg/m2). The BMD values of diabetic subjects between groups exhibited a significant gradient difference, with DML < DMM < DMH. On the fitting curves, where BMD in various skeletal regions varied with age, BMDs of DML were approximately 15% lower than those of DMM, and those of DMM were approximately 10% lower than those of DMH. For prevalence and risks of osteoporosis a gradient difference was observed among diabetic groups, DML > DMM ≈ control > DMH. The osteoporosis risk was higher for the hip than for the lumbar spine, especially in DML. This study indicated that postmenopausal women with T2DM had higher BMD and lower osteoporosis risk in the lumbar spine, and that lower BMI was an indicator of osteoporosis in mainland China.
D-brane propagation in two-dimensional black hole geometries

Y. Nakayama,S. Rey,Yuji Sugawara

DOI: https://doi.org/10.1088/1126-6708/2005/09/020

2005-07-05

Abstract:We study propagation of D0-brane in two-dimensional lorentzian black hole backgrounds by the method of boundary conformal field theory of SL(2,)/U(1) supercoset at level k. Typically, such backgrounds arise as near-horizon geometries of k coincident non-extremal NS5-branes, where 1/k measures curvature of the backgrounds in string unit and hence size of string worldsheet effects. At classical level, string worldsheet effects are suppressed and D0-brane propagation in the lorentzian black hole geometry is simply given by the Wick rotation of D1-brane contour in the euclidean black hole geometry. Taking account of string worldsheet effects, boundary state of the lorentzian D0-brane is formally constructible via Wick rotation from that of the euclidean D1-brane. However, the construction is subject to ambiguities in boundary conditions. We propose exact boundary states describing the D0-brane, and clarify physical interpretations of various boundary states constructed from different boundary conditions. As it falls into the black hole, the D0-brane radiates off to the horizon and to the infinity. From the boundary states constructed, we compute physical observables of such radiative process. We find that part of the radiation to infinity is in effective thermal distribution at the Hawking temperature. We also find that part of the radiation to horizon is in the Hagedorn distribution, dominated by massive, highly non-relativistic closed string states, much like the tachyon matter. Remarkably, such distribution emerges only after string worldsheet effects are taken exactly into account. From these results, we observe that nature of the radiation distribution changes dramatically across the conifold geometry k = 1 (k = 3 for the bosonic case), exposing the `string - black hole transition' therein.
The association between total bile acid and bone mineral density among patients with type 2 diabetes

Song Yang,Hongyun Li,Yuanyuan Gu,Qiang Wang,Li Dong,Chao Xu,Yuxin Fan,Ming Liu,Qingbo Guan,Lixing Ma

DOI: https://doi.org/10.3389/fendo.2023.1153205

IF: 6.055

2023-03-25

Frontiers in Endocrinology

Abstract:Objective: Bile acids have underlying protective effects on bones structure. Long-term diabetes also causes skeletal disorders including osteoporosis, Charcot arthropathy and renal osteodystrophy. Nevertheless, few studies have reported whether bile acid is associated with bone metabolism in diabetics. This study aimed to explore the relationship between total bile acid (TBA) and bone mineral density (BMD) among patients with type 2 diabetes mellitus (T2DM). Methods: We retrospectively included 1,701 T2DM patients who were hospitalized in Taian City Central Hospital (TCCH), Shandong Province, China between January 2017 to December 2019. The participants were classified into the osteopenia (n = 573), osteoporosis (n= 331) and control groups (n= 797) according to BMD in the lumbar spine and femoral. The clinical parameters, including TBA, bilirubin, vitamin D, calcium, phosphorus and alkaline phosphatase were compared between groups. Multiple linear regression was used to analyze the relationship between TBA and BMD in lumbar spine, femoral, trochiter, ward's triangle region. A logistic regression was conducted to develop a TBA-based diagnostic model for differentiating abnormal bone metabolism from those with normal BMD. We evaluated the performance of model using ROC curves. Results: The TBA level was significantly higher in patients with osteoporosis (Median[M]= 3.300 μmol/L, interquartile range [IQR] = 1.725 to 5.250 μmol/L) compared to the osteopenia group (M = 3.200 μmol/L, IQR = 2.100 to 5.400 μmol/L) and control group (M = 2.750 μmol/L, IQR = 1.800 to 4.600 μmol/L) ( P < 0.05). Overall and subgroup analyses indicated that TBA was negatively associated with BMD after adjusted for the co-variates (i.e., age, gender, diabetes duration, BMI, total bilirubin, direct bilirubin, indirect bilirubin) ( P < 0.05). Logistic regression revealed that higher TBA level was associated with increased risk for abnormal bone metabolism (OR = 1.044, 95% CI = 1.005 to 1.083). A TBA-based diagnostic model was established to identify individuals with abnormal bone metabolism (T-score ≤ -1.0). The area under ROC curve (AUC) of 0.767 (95% CI = 0.730 to 0.804). Conclusion: Our findings demonstrated the potential role of bile acids in bone metabolism among T2DM patients. The circulating TBA might be employed as an indicator of abnormal bone metabolism.

endocrinology & metabolism
Diabetic Microvascular Disease is Associated with a Decreased Bone Mineral Density at Hip in Type 2 Diabetes Mellitus Patients in China: A Retrospective Single Center Study

Dongmei Li,Lanlan Jiang,Bingli Liu,Yun Hu,Huan He,Kok Onn Lee,Jianhua Ma

DOI: https://doi.org/10.2139/ssrn.4111163

2022-01-01

SSRN Electronic Journal

Abstract:Backgroud: Diabetic microvascular disease(MVD) is thought to be deleterious on bone. We aimed to examine the link between the presence or number of MVD and bone mineral density (BMD) in a large cohort of Chinese patients with type 2 diabetes mellitus (T2DM).Methods: In this cross-sectional study of 10,924 patients with T2DM aged ≥50 years (5857 women), BMD was measured by dual-energy X-ray absorptiometry (DEXA). Indicators of diabetic MVD measured: diabetic retinopathy(DR), kidney disease (DKD), and peripheral neuropathy (DPN).Findings: Overall prevalence of osteopenia and osteoporosis was 39.7% and 11.9%. Lower T-score at hip (femoral neck or total hip) was associated with female sex, higher age, lower body mass index (BMI), no metformin treatment, the presence, and number of MVD. The lower T-score and higher incidence of osteoporosis or low BMD at hip was independently associated with the presence of DR (OR = 1.457, 95%CI: 1.192 – 1.781 and OR = 1.287, 95%CI: 1.159 – 1.429, both p < 0.001), or DKD (OR = 1.297, 95%CI: 1.098 – 1.533, p =0.002 and OR = 1.234, 95%CI: 1.125 – 1.354, p <0.001), DPN (OR = 1.147, 95%CI: 1.043 – 1.261, p =0.005 for low BMD only, not for osteoporosis), and the number of MVD (OR = 1.262, 95%CI: 1.138 – 1.399, and OR = 1.175, 95%CI: 1.114 – 1.239, both p < 0.001).Interpretation: The presence and number of MVD were significantly associated with lower BMD, higher incidence of osteoporosis and low BMD in dependent of sex, age, BMI, and metformin treatment.Funding: This study was funded by the National Natural Science Foundation of China (NSFC) 81870563.Declaration of Interest: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.Ethical Approval: The Institutional Review Board of the hospital approved the present study. Written informed consent was obtained from all patients.
[Decreased bone mineral density in patients with insulin-dependent-diabetes]

T Miazgowski,E Andrysiak-Mamos,S Czekalski,S Pynka

Abstract:The aim of study was an evaluation of bone mineral density (BMD) measured by LUNAR DPX-L System in lumbar spine (AP), total body and distal site of forearm (Forearm) in patients with insulin-dependent diabetes mellitus (IDDM), in relation to duration of the disease, degree of metabolic control and serum osteocalcin (OC). The study was performed on 58 patients with IDDM (26 F, 32 M; mean age: 40.1 +/- 10 yrs, mean duration of IDDM: 17.2 +/- 8 yrs) and 33 healthy, age-matched subjects (18 F, 15 M). Patients with overt nephropathy, concomitant diseases known to affect bone metabolism and women after menopause were excluded from the study. BMD was decreased in patients with IDDM in comparison with the controls: 1.13 +/- 0.1 vs 1.25 +/- 0.15 g/cm2, p < 0.001 in AP, 1.12 +/- 0.07 vs 1.2 +/- 0.07 g/cm2, p < 0.001 in Total body oraz 0.37 +/- 0.05 vs 0.4 +/- 0.05 g/cm2, p < 0.05 in Forearm. The degree of metabolic control of IDDM evaluated by serum HbAlc levels did not influence the values of BMD. Similarly, duration of IDDM did not correlate with BMD. OC level was significantly higher in diabetic patients than in control group: 4.88 +/- 2.2 vs 3.89 +/- 1.2 ng/ml, p < 0.05. Conclusions: 1) In patients with long-standing IDDM, Total Body, AP Spine and Forearm BMD were significantly decreased in comparison with the controls, and the decrease of BMD was higher in men than in women. 2) In patients with IDDM the decrease of BMD did not depend on the degree of metabolic control and duration of the disease. 3) Serum OC determinations may help in the identification of cases with risk of development of diabetic osteopenia.
Age-related bone mineral density, osteoporosis rate and risk of vertebral fracture in mainland Chinese women with type 2 diabetes mellitus

P. F. Shan,X. P. Wu,H. Zhang,X. Z. Cao,L. Q. Yuan,E. Y. Liao

DOI: https://doi.org/10.1007/BF03347065

2010-01-01

Journal of Endocrinological Investigation

Abstract:Few data are available regarding bone mineral density (BMD) and the risk of vertebral fracture among mainland Chinese women with type 2 diabetes mellitus (T2DM). A decrease in the bone projective area (BPA) can be an indirect marker reflecting compressed vertebral fracture. We investigated age-related BMD, BPA, and the prevalence of osteoporosis in women with T2DM in mainland China. BMD and BPA of the posteroanterior lumbar spine (L1–L4) and hip were measured by dual-energy X-ray absorptiometry in 1253 women with T2DM and 1194 control subjects without diabetes aged 40–80 yr. BMD of the lumbar spine and hip decreased with age. BMD of the lumbar spine was higher in T2DM than controls ( p <0.05–0.001), as was BPA at some vertebral bodies ( p <0.05–0.001), whereas no significant intergroup differences in BPA were observed at the hip. The prevalence of osteoporosis in the women with T2DM increased with age: 0–2.58% at age 40–49 yr, 6.94–28.4% at age 50–59 yr, 32.7–76.7% at age 70–80 yr, with the range reflecting differences between skeletal sites. In subjects over 60 yr, the rates of osteoporosis at posteroanterior spine were significantly lower in T2DM patients than in controls ( p <0.05–0.001). In conclusion, women with T2DM had higher BMD and lower risk of osteoporosis. Higher BPA of the vertebrae indicated that women with T2DM in mainland China would have a lower risk of vertebral fracture than non-diabetic women.
Comparison of osteoporosis in US adults with type 1 and type 2 diabetes mellitus

S C DeShields,T D Cunningham

DOI: https://doi.org/10.1007/s40618-018-0828-x

Abstract:Purpose: We examined bone mineral density (BMD) and osteoporosis prevalence in those with type 1 compared to type 2 diabetes derived from a nationally representative sample from the civilian community in the United States. Methods: Data from the National Health and Nutrition Examination Survey (NHANES) for 2005-2006, 2007-2008, 2009-2010, and 2013-2014 were merged to obtain a large sample of diabetics at least 20 years of age with participation in the interview and medical examination. Osteoporosis status was defined by BMD at the total femur, femoral neck, or total lumbar spine. Self-reported diabetics that were prescribed insulin within the first year of diagnosis, are currently taking insulin, and reported no prescriptions for any diabetic pills were classified as type 1. Remaining self-reported diabetics were deemed as having type 2. Results: A total of 2050 diabetics were included in which 87 (4%) were classified as type 1. Type 1 diabetics were found to have a significantly lower BMD at the total femur and femoral neck, but not at the lumbar spine in the adjusted models. Diabetics with type 1 were 4.7 times more likely to have osteoporosis than those with type 2. There was no significant relationship between diabetes type and BMD or osteoporosis prior to adjustment for confounders. Conclusions: Although our results show an increased likelihood of osteoporosis among those with type 1 diabetes, future studies including a larger sample from a community population are needed. It may benefit diabetics, especially those with type 1, to initiate osteoporosis screening methods including evaluation of fracture risk, bone quality, and BMD measurements at multiple sites earlier than recommended.
Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes—a meta-analysis

P. Vestergaard

DOI: https://doi.org/10.1007/s00198-006-0253-4

2006-10-27

Osteoporosis International

Abstract:Introduction and hypothesisDiabetes affects bone metabolism. The hypothesis was that type 1 (T1D) and type 2 (T2D) affects BMD and fracture risk differently.Material and methodsPubmed, Embase, and Web of Science were searched using the terms “diabetes”, “fracture”, and “bone mineral”.ResultsHip fracture risk was increased in T1D (RR = 6.94, 95% CI: 3.25–14.78, five studies) and T2D (1.38, 95% CI: 1.25–1.53, eight studies) compared to subjects without diabetes. The increase in relative hip fracture risk was significantly higher in T1D than in T2D. BMD Z-score was decreased in the spine (mean ± SEM −0.22 ± 0.01) and hip (−0.37 ± 0.16) in T1D and increased in the spine (0.41 ± 0.01) and hip (0.27 ± 0.01) in T2D. A meta-regression showed that body mass index (BMI) was a major determinant for BMD in both the spine and hip. Glycated haemoglobin (HbA1C) was not linked to BMD. The increase in fracture risk was higher and BMD lower in patients with complications to diabetes.ConclusionsHip fracture risk is increased in both T1D and T2D, whereas BMD is increased in T2D and decreased in T1D. A common factor such as complications may explain the increase in fracture risk, whereas BMI may ameliorate the increase in fracture risk in T2D.

endocrinology & metabolism
D-dimer in the diagnostic workup of suspected pulmonary embolism: additional clinical value of pretest probability.

R. Cacciola,E. Cacciola,R. Polosa

DOI: https://doi.org/10.1016/S0012-3692(15)34520-7

IF: 9.6

2005-04-01

Chest

Abstract:
Low Bone Turnover Markers in Young and Middle-Aged Male Patients with Type 2 Diabetes Mellitus

X X Liu,L Jiang,Q Liu,J Zhang,W Niu,J Liu,Q Zhang

DOI: https://doi.org/10.1155/2020/6191468

2020-08-10

Abstract:Accumulating evidence has supported an increased risk of osteoporotic fracture in postmenopausal women and elderly men diagnosed with diabetes mellitus. However, it is not uncommon for young and middle-aged male patients diagnosed with type 2 diabetes mellitus (T2DM) to suffer from osteopenia or osteoporosis. Few studies focused on this population group are available. The aim of this study is to evaluate bone metabolic status and investigate the influence of T2DM on bone metabolism in 30-50-year-old men. Anthropometric assessment and blood samples were obtained from 160 patients with T2DM and 69 nondiabetic volunteers. Serum parathyroid hormone (PTH) and bone turnover markers (BTMs), including serum procollagen type I N-terminal peptide (PINP), osteocalcin (OC), and β-cross-linked C-telopeptide of type I collagen (β-CTX), were analysed. No significant differences were observed based on age, body mass index, systolic blood pressure, serum calcium, phosphorus, creatinine, total protein, and albumin levels when comparing T2DM and control groups. Fasting blood glucose, HbA1c, triglyceride (TG), total cholesterol, and low-density lipoprotein cholesterol were significantly increased, while high-density lipoprotein cholesterol was significantly decreased in the T2DM group. Compared with controls, diabetic patients showed lower serum PINP, OC, and PTH levels, whereas serum β-CTX levels were similar between the two groups. Moreover, HbA1c levels were positively correlated with PINP and inversely associated with PTH levels. TG levels were negatively correlated with OC or β-CTX levels. Furthermore, multiple linear regression revealed a positive correlation between HbA1c and PINP levels. These results also revealed a negative association between HbA1c and PTH, and between TG and OC levels, even after adjusting for expected confounder factors. Collectively, these findings indicated that young and middle-aged male patients with T2DM showed a lower turnover state resulting from bone formation inhibition. Glucose and lipid metabolic disorders may affect bone formation through different pathways.
High-normal free thyroxine level is related with decreased bone mineral density in nonobese male patients with type 2 diabetes over 50 years old

Hanxin Zhao,Dike Shi,Guoxing Wang,Yu Ruan,Xiaocheng Feng,ChengFang Jia,Qingqing Wang,Xuehong Dong

DOI: https://doi.org/10.1177/20406223231195627

2023-08-31

Abstract:Background: The prevalence of 'low bone mineral density (BMD)' in Type 2 diabetes (T2DM), especially stratified by body mass index, is seldom reported. The relation of the euthyroid range and low BMD in T2DM remains to be further elucidated. Objectives: We aim to investigate the thyroid hormones' impact on BMD among euthyroid patients with T2DM. Design and methods: A total of 1452 hospitalized T2DM patients with normal thyroid function (43.6% males aged over 50 and 56.4% postmenopausal females) were enrolled in this cross-sectional study. BMD was measured at lumbar spine by GE lunar dual-energy X-ray absorptiometry system, and 'low BMD' was defined as T-score <-1.0 SD. The prevalence of 'low BMD' was compared between obese and nonobese (body mass index < 25 kg/m2) groups for both sexes, and the relation of low BMD and free T4 quartiles was explored by multiple logistic regression. Results: The general prevalence of 'low BMD' was 12.3% for male patients aged over 50 (15.5% in the nonobese group and 8.0% in the obese group) and 49.8% for postmenopausal females (56.7% in the nonobese group and 48.9% in the obese group). After adjustment in multiple linear regression, free T4 level remained significantly related to decreased BMD in nonobese male subgroup. Multiple logistic regression revealed that BMD of the highest free T4 quartile (1.12-1.48 ng/dL) decreased significantly than other three quartiles after adjusting for confounding factors including age, body mass index, serum calcium and creatinine level, fasting glucose, alkaline phosphatase, glycosylated hemoglobin, total cholesterol, and smoking history (OR = 2.724, 95% CI = 1.085-6.840, p = 0.033). No significant relation was found in obese male or postmenopausal female groups. Conclusion: High-normal free T4 is a potential independent risk factor for 'low BMD' in nonobese male T2DM patients aged over 50. Close attention should be paid to thyroid function profile, even within normal range, in nonobese men with underlying higher fracture risks on diabetes status.
Unaffected bone mineral density in Danish children and adolescents with type 1 diabetes

Jens Otto Broby Madsen,Camilla Winther Herskin,Bo Zerahn,Andreas Kryger Jensen,Niklas Rye Jørgensen,Birthe Susanne Olsen,Flemming Pociot,Jesper Johannesen

DOI: https://doi.org/10.1007/s00774-019-01058-0

2019-11-21

Journal of Bone and Mineral Metabolism

Abstract:AimsAdults with type 1 diabetes mellitus (T1D) have decreased bone mineral density (BMD). Our study aimed at determining BMD and the association to metabolic control in children and adolescents with T1D.Methods244 patients (113 girls) with a median age of 14.3 years and T1D duration of 1–16 years were included. A dual-energy X-ray absorptiometry scan assessed BMD Z-scores excluding the head (total body less head, TBLH). TBLH-BMD were then investigated for associations to diabetes relevant variables such as HbA1c, insulin treatment, anthropometry and physical activity.ResultsIn all participants the TBLH-BMD Z-score (0.22 ± 0.96) was significantly higher than the references. Separated by sex, TBLH-BMD Z-score in boys (0.11 ± 0.84) was no different from healthy peers whereas TBLH-BMD Z-score was significantly higher in girls (0.36 ± 1.09). The higher TBLH-BMD Z-score in girls were explained by higher BMI Z-scores. Participants with assumed final height (based on age) had an average TBLH-BMD Z-score of 0.78 ± 1.06, significantly higher than references independent of gender, HbA1c, height- and weight Z-scores. Multiple regression analyses showed that TBLH BMD Z-score associated negatively to HbA1c (P = 0.003), pump treatment (P = 0.019) and screen-time (P = 0.005) and positively to weight Z-score (P < 0.001). Physical activity, sex and puberty did not significantly associate to TBLH-BMD Z-score.ConclusionUnlike adults with T1D, BMD is not decreased in children and adolescents with T1D and even elevated after attained final height. As HbA1c negatively associates to BMD, decreased BMD may progress over time. Whether changes in microarchitecture or bone metabolism precede changes in BMD needs further investigation.

endocrinology & metabolism,medicine, research & experimental
Letter: the addition of an immunosuppressant in patients with unsatisfactory response to vedolizumab—Authors' reply

A. Strik,G. D'Haens

DOI: https://doi.org/10.1111/apt.14570

2018-04-01

Abstract:vere articular manifestations may persist. In these cases, the use of an immunomodulator—particularly methotrexate—is only intended to obtain a control of articular symptoms. Second, the addition of an immunomodulator to vedolizumab monotherapy can improve clinical benefit when vedolizumab monotherapy did not obtain complete control of intestinal symptoms. In this line, a recent study by Allegretti et al showed that the addition of an immunomodulator to vedolizumab was an independent predictor of clinical response or remission at week 54 among patients with Crohn’s disease, while a recent case series comprising 4 patients showed that the addition of methotrexate to vedolizumab did not obtain a clinical response and did not improve the pharmacokinetic profile of the drug. Consequently, we believe that our promising—but preliminary—results may be secondary to the addition of the therapeutic effect of the immunomodulator to that of vedolizumab, rather than to a pharmacokinetic benefit similar to that observed with anti-TNF combination therapies.
Low TSH Levels Within Euthyroid Range Could Play a Negative Role on Bone Mineral Density in Postmenopausal Women with Type 2 Diabetes

Congying Liu,Junhong Pan,Song Wen,Thiquynhnga Nguyen,Dongxiang Xu,Chaoxun Wang,Xinlu Yuan,Zhongqiu Wen,Ligang Zhou

DOI: https://doi.org/10.2147/dmso.s307633

2021-01-01

Abstract:Objective We aimed to evaluate the relationship between thyroid-stimulating hormone (TSH) and bone mineral density (BMD) in euthyroid type 2 diabetes (T2D). Methods This retrospective analysis enrolled 439 T2D patients with normal thyroid function, including 226 males and 213 females. All the female patients were postmenopausal. Serum glycosylated hemoglobin A1c (HbA1c), TSH, free triiodothyronine (FT3), and free thyroxine (FT4) concentrations were analyzed. BMD of the lumbar spine (L1–L4), femoral neck, and hip joint was determined using dual-energy X-ray absorptiometry. Results The patients were grouped based on tri-sectional quantiles of the TSH levels: 0.55~1.70mIU/L (Group 1), 1.71~2.58mIU/L (Group 2), and 2.59~4.74mIU/L (Group 3). Our data showed that, in male patients, no difference in BMD was identified among groups. In postmenopausal women, unlike at the lumbar spine (P = 0.459), the mean BMD at the femoral neck (P = 0.014) and hip joint (P = 0.014) had a statistical difference among groups and increased with TSH level. In addition, our analysis demonstrated that TSH levels shown no correlation with BMD at all sites in males. However, in females, BMD at the femoral neck (r = 0.156, P = 0.023) and hip joint (r = 0.172, P = 0.012) had a positive correlation with TSH levels. After adjusting for age and BMI, multiple regression analysis showed that TSH levels influenced BMD at the femoral neck (β = 0.188, P = 0.001) and hip joint (β = 0.204, P = 0.001) in female patients. Conclusion In summary, our data demonstrates that low TSH levels are associated with decreased BMD at the femoral neck and hip joint in postmenopausal T2D women with euthyroidism.
Diabetes and osteoporosis: a two-sample mendelian randomization study

Yu-Dun Qu,Zhao-Hua Zhu,Jia-Xuan Li,Wei Zhang,Qi Chen,Chang-Liang Xia,Jun-Nan Ma,Shuan-Ji Ou,Yang Yang,Yong Qi,Chang-Peng Xu

DOI: https://doi.org/10.1186/s12891-024-07430-0

IF: 2.562

2024-04-23

BMC Musculoskeletal Disorders

Abstract:Abstract Background The effects on bone mineral density (BMD)/fracture between type 1 (T1D) and type 2 (T2D) diabetes are unknown. Therefore, we aimed to investigate the causal relationship between the two types of diabetes and BMD/fracture using a Mendelian randomization (MR) design. Methods A two-sample MR study was conducted to examine the causal relationship between diabetes and BMD/fracture, with three phenotypes (T1D, T2D, and glycosylated hemoglobin [HbA1c]) of diabetes as exposures and five phenotypes (femoral neck BMD [FN-BMD], lumbar spine BMD [LS-BMD], heel-BMD, total body BMD [TB-BMD], and fracture) as outcomes, combining MR-Egger, weighted median, simple mode, and inverse variance weighted (IVW) sensitivity assessments. Additionally, horizontal pleiotropy was evaluated and corrected using the residual sum and outlier approaches. Results The IVW method showed that genetically predicted T1D was negatively associated with TB-BMD ( β = -0.018, 95% CI: -0.030, -0.006), while T2D was positively associated with FN-BMD ( β = 0.033, 95% CI: 0.003, 0.062), heel-BMD ( β = 0.018, 95% CI: 0.006, 0.031), and TB-BMD ( β = 0.050, 95% CI: 0.022, 0.079). Further, HbA1c was not associated with the five outcomes ( β ranged from − 0.012 to 0.075). Conclusions Our results showed that T1D and T2D have different effects on BMD at the genetic level. BMD decreased in patients with T1D and increased in those with T2D. These findings highlight the complex interplay between diabetes and bone health, suggesting potential age-specific effects and genetic influences. To better understand the mechanisms of bone metabolism in patients with diabetes, further longitudinal studies are required to explain BMD changes in different types of diabetes.

rheumatology,orthopedics
Bone Marrow Adiposity Alterations in Postmenopausal Women With Type 2 Diabetes Are Site-Specific

Sammy Badr,Anne Cotten,Daniela Lombardo,Stefan Ruschke,Dimitrios C Karampinos,Nassima Ramdane,Michael Genin,Julien Paccou

DOI: https://doi.org/10.1210/jendso/bvae161

2024-09-13

Abstract:Context: Bone marrow adiposity (BMAT) alterations in patients with type 2 diabetes mellitus (T2DM) may contribute to adverse bone effects. Objective: Characterization of BMAT content and composition in patients with well-controlled T2DM. Methods: This cross-sectional study included 2 groups of postmenopausal women: one with T2DM and the other without. The proton density fat fraction (PDFF) of the lumbar spine and proximal femur, comprising the femoral head, neck, and diaphysis, was assessed using chemical shift-based water-fat separation imaging (WFI). Magnetic resonance imaging with spectroscopy (1H-MRS) was performed in a subgroup of participants to confirm the PDFF measurements and determine the apparent lipid unsaturation level (aLUL) at the L3 vertebrae and femoral neck. The association of imaging-based PDFFs and aLUL between diabetes groups was investigated by adjusting for confounding factors using a linear mixed model. Results: Among 199 participants, patients with T2DM (n = 29) were significantly heavier (P < .001) and had a higher bone mineral density (BMD) (P < .001 for all sites) than nondiabetic patients (n = 170). When PDFFs were compared after adjusting for age, body mass index (BMI), and BMD, the femoral head WFI-based PDFF was lower in patients with T2DM (mean [standard error] 88.0% [0.7] vs 90.6% [0.3], P < .001). Moreover, the aLUL at the L3 vertebrae was lower in patients with T2DM (n = 16) than in without (n = 97) (mean [standard error] 3.9% [0.1] vs 4.3% [0.1], P = .02). Conclusion: The content and composition of BMAT are modified in postmenopausal women with T2DM and these changes occur at specific sites.
Association between bone turnover markers, bone mineral density, and serum osteoglycine in middle-aged men with Type 2 Diabetes mellitus

Salma Mohamed Mostafa,Ibrahim Elebrashy,Hemmat El Haddad,Olfat Shaker,Naglaa Abdel Razek,Ahmed Fayed

DOI: https://doi.org/10.1186/s13098-024-01388-8

2024-07-09

Abstract:Background: Patients with Type 2 diabetes mellitus (T2DM) have decreased bone health. We aimed to investigate serum levels of bone turnover markers (BTMs) (markers of bone formation and bone resorption) and bone mineral density (BMD) at three sites (lumber, neck femur, and total femur) in middle-aged men with type 2 diabetes and to analyze the relationship between them. Also to evaluate serum osteoglycin as a novel marker and its relation to BTMs, BMD, and diabetic status. Methods: We recruited seventy-eight patients with T2DM and thirteen non-diabetic, male volunteers as a control group. BMD was measured using a DEXA scan. BTMs (carboxy-terminal crosslinking telopeptide of type 1 collagen [CTX] and procollagen type 1 N propeptide [P1NP]), osteoglycin, PTH, and vitamin D were estimated. Data was compared among subjects and statistical analysis was performed. Results: Most of the patients were having normal BMD with no significant difference between patients and the controls. BTMs and osteoglycin were significantly higher and vitamin D was significantly lower in the diabetic patients. Serum osteoglycin was positively correlated with DEXA Neck Femur (r = 0.233; p-value < 0.05). Conclusion: Body mass index and Serum osteoglycin have a significant positive effect on BMD. Both markers of bone formation and bone resorption were increased indicating a state of increased bone turnover in T2DM.

Unusual Right‐Sided Cardiac Masses

Association Between Bone Mineral Density and Type 2 Diabetes Mellitus: a Meta-Analysis of Observational Studies

Bone mineral density and factors influencing it in Asian Indian population with type 2 diabetes mellitus

The effects of anesthesia on middle‐eae effusions

Bone Mineral Density and Its Relationship with Body Mass Index in Postmenopausal Women with Type 2 Diabetes Mellitus in Mainland China

D-brane propagation in two-dimensional black hole geometries

The association between total bile acid and bone mineral density among patients with type 2 diabetes

Diabetic Microvascular Disease is Associated with a Decreased Bone Mineral Density at Hip in Type 2 Diabetes Mellitus Patients in China: A Retrospective Single Center Study

[Decreased bone mineral density in patients with insulin-dependent-diabetes]

Age-related bone mineral density, osteoporosis rate and risk of vertebral fracture in mainland Chinese women with type 2 diabetes mellitus

Comparison of osteoporosis in US adults with type 1 and type 2 diabetes mellitus

Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes—a meta-analysis

D-dimer in the diagnostic workup of suspected pulmonary embolism: additional clinical value of pretest probability.

Low Bone Turnover Markers in Young and Middle-Aged Male Patients with Type 2 Diabetes Mellitus

High-normal free thyroxine level is related with decreased bone mineral density in nonobese male patients with type 2 diabetes over 50 years old

Unaffected bone mineral density in Danish children and adolescents with type 1 diabetes

Letter: the addition of an immunosuppressant in patients with unsatisfactory response to vedolizumab—Authors' reply

Low TSH Levels Within Euthyroid Range Could Play a Negative Role on Bone Mineral Density in Postmenopausal Women with Type 2 Diabetes

Diabetes and osteoporosis: a two-sample mendelian randomization study

Bone Marrow Adiposity Alterations in Postmenopausal Women With Type 2 Diabetes Are Site-Specific

Association between bone turnover markers, bone mineral density, and serum osteoglycine in middle-aged men with Type 2 Diabetes mellitus